Health Equity

As new federal rules threaten healthcare for thousands, Gold Coast Health Plan is funding local groups to help vulnerable residents navigate the changes.

Teva and Medincell’s once-monthly olanzapine injection shows promise in trials, potentially freeing patients from burdensome post-injection observation.

The FDA is reviewing a new, more affordable alternative to the costly arthritis drug Orencia, potentially saving patients and the healthcare system billions.

A new study reveals adults with IDD are 9x more likely to have anxiety or depression, yet face immense barriers to care. This is a systemic failure.

Dr. Joss Reimer, a veteran of Manitoba's COVID-19 response, takes the helm at PHAC, facing a slate of crises from measles to misinformation.

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

Atlanta's World Neuroscience Day Conference returns to explore the brain-heart connection, demystify clinical trials, and empower a growing community.

For the 13th straight year, LocumTenens.com has won top service awards, setting a gold standard in a healthcare staffing market facing critical shortages.

The deal, backed by private equity, aims to streamline complex Medicaid billing, impacting both hospital finances and patient access to care.

New research reveals the UK's booming sauna culture is more than just heat; it's a powerful social tool that could be prescribed to combat loneliness.

California University of Science and Medicine achieves top national accreditation, a major validation of its mission to fix the region's critical doctor shortage.

Nemours Foundation adds Advocate Health's Dr. Betty Chu to its board, a strategic move to leverage her expertise in quality, equity, and large-scale operations.

A new book reveals why physician marriages are surprisingly stable and what every dual-career couple can learn from their success in balancing love and life.

A new online pharmacy is challenging the 'prescribe and forget' model for weight loss drugs, offering integrated clinical care to combat safety concerns.

SkyMD's new virtual therapy service targets New Mexico's deep provider shortages and access issues, but enters a competitive and complex digital market.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

Aethlon Medical advances its Hemopurifier for oncology and Long COVID, but a shrinking cash reserve and rising quarterly loss test its lean science strategy.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

Texas Athletics and supplement brand Humann partner to turn basketball games into a live lesson on heart health, blending science, sports, and marketing.

In a landmark move, the FDA has removed major risk warnings from hormone therapy drugs, signaling a new era for women's health after decades of fear.